Plain-English translation of NCT04831983 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This trial is testing a new approach to treating prostate cancer using image-guided radiotherapy—a precise, single-session radiation treatment that delivers a high dose directly to the tumor while protecting healthy tissue nearby. You would receive this treatment along with standard hormone therapy. The researchers want to understand how well this approach works and what side effects patients experience.
For men with aggressive prostate cancer, standard treatments can take many weeks or months. This trial is exploring whether delivering the full radiation dose in just one session—with extra precision targeting the tumor—might be equally effective while being faster and potentially easier for patients to tolerate.
You likely qualify if…
You likely don't qualify if…
You would receive a single radiation treatment session lasting about 1–2 hours, during which real-time imaging keeps the treatment focused on your tumor. You would also receive hormone therapy as part of standard care. After treatment, you would return for follow-up visits at 1 month, then every 3 months for the first year, then every 6 months afterward. At these visits, you would complete questionnaires about your quality of life, urinary function, and sexual function, and have blood tests to monitor your cancer.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Italy